Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia

Fig. 5

TNFAIP2 expression and clinical features in AML patients in TCGA dataset. a Comparison of TNFAIP2 expression level among different subtypes of AML in the distribution of FAB classifications analyzed by UALCAN. b Comparison of TNFAIP2 expression level in AML patients according to cytogenetic risk stratification. c Comparison of TNFAIP2 expression level in AML patients according to NPM1 gene mutation status

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us